Introduction: The beneficial effect of hydroxychloroquine (HCQ) in decreasing LDL levels on Systemic Lupus Erythematosus (SLE) is well defined. The influence of this drug on HDL levels is still under debate and information about its effect on cholesterol reverse transport is lacking.
Objective: To evaluate the effects of HCQ on HDL levels and the transfer of lipids to this lipoprotein in SLE.